Drug intelligence / Profile preview

furosemide + prednisolone

Development stage
Unknown
Lead developer
Sanofi
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Furosemide + prednisolone is a combination of two pharmaceutical drugs, each with distinct mechanisms and indications. Furosemide is a loop diuretic that acts on the kidneys to increase the excretion of sodium, chloride, and water, thereby reducing fluid overload in conditions such as heart failure, liver cirrhosis, renal disease (including nephrotic syndrome), and hypertension. Prednisolone is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive properties; it binds to the glucocorticoid receptor to modulate gene expression and suppress pro-inflammatory pathways. This combination may be used in clinical scenarios where both diuresis (fluid removal) and anti-inflammatory or immunosuppressive effects are required—such as severe edema associated with inflammatory or autoimmune diseases—but must be used cautiously due to an increased risk of hypokalemia (low potassium) from additive effects on electrolyte balance[5][1].

02

Targets

GR (Glucocorticoid receptor)NKCC2 (Sodium-potassium-chloride cotransporter 2)

Beyond the preview

Go deeper on furosemide + prednisolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on furosemide + prednisolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call